These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 9793176)
1. [Nuclear-cytoplasmic distribution of MAP-kinase isoforms p42 and p44 after treatment with epidermal growth factors (EGF) of cells with different functional state of EGF receptor]. Arnautov AM; Nikol'skiĭ NN Tsitologiia; 1998; 40(7):633-8. PubMed ID: 9793176 [TBL] [Abstract][Full Text] [Related]
2. [Transport into the cell nucleus of p42 and p44 isoforms of MAP kinase induced by epidermal growth factor requires the presence of intact active cytoskeleton]. Arnautov AM; Nikol'skiĭ NN Tsitologiia; 1998; 40(7):639-47. PubMed ID: 9793177 [TBL] [Abstract][Full Text] [Related]
3. Nuclear translocation of p42/p44 mitogen-activated protein kinase is required for growth factor-induced gene expression and cell cycle entry. Brunet A; Roux D; Lenormand P; Dowd S; Keyse S; Pouysségur J EMBO J; 1999 Feb; 18(3):664-74. PubMed ID: 9927426 [TBL] [Abstract][Full Text] [Related]
4. Response to transforming growth factor alpha (TGFalpha) and epidermal growth factor (EGF) in hepatocytes: lower EGF receptor affinity of TGFalpha is associated with more sustained activation of p42/p44 mitogen-activated protein kinase and greater efficacy in stimulation of DNA synthesis. Thoresen GH; Guren TK; Sandnes D; Peak M; Agius L; Christoffersen T J Cell Physiol; 1998 Apr; 175(1):10-8. PubMed ID: 9491776 [TBL] [Abstract][Full Text] [Related]
5. Growth factor-induced p42/p44 MAPK nuclear translocation and retention requires both MAPK activation and neosynthesis of nuclear anchoring proteins. Lenormand P; Brondello JM; Brunet A; Pouysségur J J Cell Biol; 1998 Aug; 142(3):625-33. PubMed ID: 9700154 [TBL] [Abstract][Full Text] [Related]
6. Convergence of progesterone and epidermal growth factor signaling in breast cancer. Potentiation of mitogen-activated protein kinase pathways. Lange CA; Richer JK; Shen T; Horwitz KB J Biol Chem; 1998 Nov; 273(47):31308-16. PubMed ID: 9813039 [TBL] [Abstract][Full Text] [Related]
7. Sustained mitogen-activated protein kinase activation is induced by transforming erbB receptor complexes. Wu CJ; Qian X; O'Rourke DM DNA Cell Biol; 1999 Oct; 18(10):731-41. PubMed ID: 10541432 [TBL] [Abstract][Full Text] [Related]
8. Endothelin-mediated vascular growth requires p42/p44 mitogen-activated protein kinase and p70 S6 kinase cascades via transactivation of epidermal growth factor receptor. Iwasaki H; Eguchi S; Ueno H; Marumo F; Hirata Y Endocrinology; 1999 Oct; 140(10):4659-68. PubMed ID: 10499523 [TBL] [Abstract][Full Text] [Related]
9. Intercellular heterogeneity of early mitogenic events: cAMP generalizes the EGF effect on c-Fos protein appearance but not on MAP kinase phosphorylation and nuclear translocation in dog thyroid epithelial cells. Baptist M; Dumont JE; Roger PP Exp Cell Res; 1995 Nov; 221(1):160-71. PubMed ID: 7589241 [TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor (EGF) receptor blockade inhibits the action of EGF, insulin-like growth factor I, and a protein kinase A activator on the mitogen-activated protein kinase pathway in prostate cancer cell lines. Putz T; Culig Z; Eder IE; Nessler-Menardi C; Bartsch G; Grunicke H; Uberall F; Klocker H Cancer Res; 1999 Jan; 59(1):227-33. PubMed ID: 9892211 [TBL] [Abstract][Full Text] [Related]
11. Estradiol-induced phosphorylation of serine 118 in the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase. Joel PB; Traish AM; Lannigan DA J Biol Chem; 1998 May; 273(21):13317-23. PubMed ID: 9582378 [TBL] [Abstract][Full Text] [Related]
12. Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172). Ahn HY; Hadizadeh KR; Seul C; Yun YP; Vetter H; Sachinidis A Mol Biol Cell; 1999 Apr; 10(4):1093-104. PubMed ID: 10198059 [TBL] [Abstract][Full Text] [Related]
13. Parathyroid hormone activates mitogen-activated protein kinase in opossum kidney cells. Cole JA Endocrinology; 1999 Dec; 140(12):5771-9. PubMed ID: 10579343 [TBL] [Abstract][Full Text] [Related]
14. Platelet-derived-growth-factor stimulation of the p42/p44 mitogen-activated protein kinase pathway in airway smooth muscle: role of pertussis-toxin-sensitive G-proteins, c-Src tyrosine kinases and phosphoinositide 3-kinase. Conway AM; Rakhit S; Pyne S; Pyne NJ Biochem J; 1999 Jan; 337 ( Pt 2)(Pt 2):171-7. PubMed ID: 9882612 [TBL] [Abstract][Full Text] [Related]
15. EGF triggers neuronal differentiation of PC12 cells that overexpress the EGF receptor. Traverse S; Seedorf K; Paterson H; Marshall CJ; Cohen P; Ullrich A Curr Biol; 1994 Aug; 4(8):694-701. PubMed ID: 7953555 [TBL] [Abstract][Full Text] [Related]
16. Bradykinin-induced p42/p44 MAPK phosphorylation and cell proliferation via Src, EGF receptors, and PI3-K/Akt in vascular smooth muscle cells. Yang CM; Lin MI; Hsieh HL; Sun CC; Ma YH; Hsiao LD J Cell Physiol; 2005 Jun; 203(3):538-46. PubMed ID: 15573401 [TBL] [Abstract][Full Text] [Related]
17. The role of protein kinases A and C pathways in the regulation of mitogen-activated protein kinase activation in response to gonadotropin-releasing hormone receptor activation. Han XB; Conn PM Endocrinology; 1999 May; 140(5):2241-51. PubMed ID: 10218977 [TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor (EGF) receptor carboxy-terminal domains are required for EGF-induced glucose transport in transgenic 3T3-L1 adipocytes. Hardy RW; Gupta KB; McDonald JM; Williford J; Wells A Endocrinology; 1995 Feb; 136(2):431-9. PubMed ID: 7835273 [TBL] [Abstract][Full Text] [Related]
19. G alpha(i-2) mediates renal LLC-PK1 growth by a Raf-independent activation of p42/p44 MAP kinase. Kinane TB; Kang I; Chu A; Chin SH; Ercolani L Am J Physiol; 1997 Feb; 272(2 Pt 2):F273-82. PubMed ID: 9124407 [TBL] [Abstract][Full Text] [Related]
20. Potent SHC tyrosine phosphorylation by epidermal growth factor at low receptor density or in the absence of receptor autophosphorylation sites. Soler C; Alvarez CV; Beguinot L; Carpenter G Oncogene; 1994 Aug; 9(8):2207-15. PubMed ID: 8036006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]